Gs protein mutations and the pathogenesis and function of pituitary tumors
- 31 August 1996
- journal article
- review article
- Published by Elsevier in Metabolism
- Vol. 45, 120-122
- https://doi.org/10.1016/s0026-0495(96)90104-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The cyclic adenosine 3',5'-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomasMolecular Endocrinology, 1995
- Biochemical characteristics of human pituitary somatotropinomas with and without gsp mutations: in vitro cell culture studiesJournal of Clinical Endocrinology & Metabolism, 1995
- Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's diseaseJournal of Clinical Endocrinology & Metabolism, 1992
- Clonal Origin of Pituitary Adenomas*Journal of Clinical Endocrinology & Metabolism, 1990
- Clinical, Biochemical, and Morphological Correlates in Patients Bearing Growth Hormone-Secreting Pituitary Tumors with or without Constitutively Active Adenylyl CyclaseJournal of Clinical Endocrinology & Metabolism, 1990
- Clinical Characteristics of Acromegalic Patients whose Pituitary Tumors Contain Mutant GsProteinJournal of Clinical Endocrinology & Metabolism, 1990
- Two G Protein Oncogenes in Human Endocrine TumorsScience, 1990
- Clinically nonfunctioning pituitary tumors are monoclonal in origin.Journal of Clinical Investigation, 1990
- GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumoursNature, 1989
- Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomasNature, 1987